bmi to qualify for glp 1 Zepbound on Medicare: $50 Copays Starting July (GLP-1 Bridge) Efficacy of GLP-1 on weight

doi: 10.1016/j.obpill.2024.100121 30

Values presented as percentage of total Adverse events are presented for all participants who were randomised and took at least one dose of treatment, regardless of whether they discontinued * For the T2D trial, this was limited to supraventricular arrhythmias and cardiac conduction disorders ** For the obesity trial these are presented as hepatic disorder / biliary disorder separately NA : Not applicable In the obesity trial, serious adverse events (SAEs) occurred in 4% of participants with retatrutide use overall (06% across groups) vs

For someone following a tirzepatide dosage calculator based on the labeled amount, they would unknowingly be taking a significantly higher dose

Improving health literacy Strategies to improve health literacy in people with type 2 diabetes can not only increase their understanding of the importance of preventing diabetes-related vascular complications but can also motivate them to access healthcare providers more frequently and to actively participate in the discussion with their clinician regarding treatment with potentially cardioprotective drugs including GLP-1 RAs [30, 31, 71]

The product has been received very well by the doctor community and one of the differentiating points is our auto-injector as well as the pen system which was appreciated by the doctors and patients equally well. Kirti Ganorkar, Managing Director, Sun Pharma | Q4 FY26 Bet 4 Sit out the rush Mankind Pharma did something none of its peers did